1. European healthcare policies for controlling drug expenditures;Ess;Pharmacoeconomics,2003
2. Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs;Kanavos;Health Affairs,2013
3. Funding health care: options for Europe;Mossialos,2002
4. Generic entry in prescription medicines in the EU: main characteristics, determinants and effects;Glowicka,2009
5. R.Caves, M.Whinston, M.Hurwitz, Patent expiration, entry, and competition in the US pharmaceutical industry in: MN Bailey and C Winston (eds.) Brookings Papers on Economic Activity - Microeconomics, 1991, 1-66; Washington DC